Group 1 - The company Zhejiang Chengyi Pharmaceutical Co., Ltd. has signed a maximum guarantee contract with Xiamen Bank Co., Ltd. Nanping Branch, providing a joint liability guarantee for its subsidiary Fujian Huakang Pharmaceutical Co., Ltd. with a maximum amount of 35 million yuan from November 28, 2025, to November 28, 2026 [2] - The company plans to provide a guarantee amount not exceeding 80 million yuan for Fujian Huakang Pharmaceutical Co., Ltd. in the fiscal year 2025, as part of a comprehensive credit facility application totaling no more than 2 billion yuan [3][7] - As of the announcement date, the total amount of guarantees provided by the company and its subsidiaries is 50 million yuan, which accounts for 3.97% of the company's latest audited net assets [8] Group 2 - The guarantee covers all principal, interest, penalties, and other related costs as specified in the contract, including fees for collection, litigation, and other expenses incurred by the creditor [5][6] - The guarantee period is calculated based on the debt performance period specified in each individual credit document, lasting until three years after the maturity of each specific principal debt [6] - The company asserts that the guarantee is necessary and reasonable to meet the operational needs of its subsidiary, with no adverse impact on the company's normal operations or shareholder interests [7]
浙江诚意药业股份有限公司关于提供担保进展情况的公告